Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Clinical Cancer Research 14, 2249-2252, April 15, 2008. doi: 10.1158/1078-0432.CCR-07-1005
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Braun, B. S.
Right arrow Articles by Shannon, K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braun, B. S.
Right arrow Articles by Shannon, K.

Molecular Pathways

Targeting Ras in Myeloid Leukemias

Benjamin S. Braun and Kevin Shannon

Authors' Affiliation: Department of Pediatrics, University of California, San Francisco

Requests for reprints: Benjamin S. Braun or Kevin Shannon, HSE 302, Box 0519, Department of Pediatrics, University of California San Francisco, 513 Parnassus Avenue, San Francisco, California 94143. Phone: 415-476-2876; Fax: 415-502-5127; E-mail: braunb{at}peds.ucsf.edu or shannonk{at}peds.ucsf.edu.

Abstract

Ras proteins normally relay growth-promoting signals from many activated cell surface receptors, and they are altered by oncogenic point mutations in ~30% of human cancers. Activating KRAS and NRAS mutations are especially common in malignancies of the pancreas, lung, and colon, and in myeloid leukemia. Here, we discuss general strategies for targeting hyperactive Ras signaling in cancer cells with specific reference to myeloid malignancies.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2008 by the American Association for Cancer Research.